v3.26.3
Unaudited Condensed Statements of Cash Flows - USD ($)
 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash Flows from Operating Activities:    
Net income $ 2,958,316 $ 2,548,010
Adjustments to reconcile net income to net cash used in operating activities:    
Interest earned on marketable securities held in Trust Account (3,994,545) (3,119,056)
Payment of operating costs through IPO Promissory Note – related party 37,574
Changes in operating assets and liabilities:    
Prepaid expenses 15,348 (106,974)
Due from Sponsor (13,783) (550)
Long-term prepaid insurance 16,517 (35,024)
Accrued expenses 143,963 74,774
Net cash used in operating activities (874,184) (601,246)
Cash Flows from Investing Activities:    
Investment of cash in Trust Account (144,181,250)
Net cash used in investing activities (144,181,250)
Cash Flows from Financing Activities:    
Proceeds from sale of Public Units, net of underwriting discounts paid 140,875,000
Proceeds from sale of Private Placement Units 5,656,250
Repayment of IPO Promissory Note – related party (162,616)
Payment of offering costs (80,000) (273,309)
Net cash (used in) provided by financing activities (80,000) 146,095,325
Net Change in Cash (954,184) 1,312,829
Cash – Beginning of period 1,093,209
Cash – End of period 139,025 1,312,829
Non-cash investing and financing activities:    
Offering costs included in accrued offering costs 62,500
Deferred offering costs paid through IPO Promissory Note – related party 112,542
Deferred Fee payable $ 5,031,250